
Mensheild Pharmaceutical Private Limited
Founded in 2016 and headquartered in Uttar Pradesh, India.
Founded in 2016 and headquartered in Uttar Pradesh, India.
Ghaziabad, Uttar Pradesh, India
+91-XXXXXXXXXX
U74999UP2016PTC088766
088766
Private Limited Indian Non-Government Company
29 Dec 2016
29 Sep 2018
31 Mar 2018
Unlisted
Roc Kanpur
Name | Designation | Appointment Date | Status |
---|---|---|---|
Pankaj Joshi ![]() | Director | 29-Dec-2016 | Current |
Apoorva Chaudhary ![]() | Director | 29-Dec-2016 | Current |
Mensheild Pharmaceutical Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
In 2017, Mensheild Pharmaceutical had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Pankaj Joshi is a mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Mensheild Pharmaceutical, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Mensheild Pharmaceutical, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Mensheild Pharmaceutical's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Mensheild Pharmaceutical Private Limited last Annual general meeting of members was held on 29 Sep 2018 as per latest MCA records.
Mensheild Pharmaceutical Private Limited has filed its annual Financial statements for the year ended 31 Mar 2018 with Roc Kanpur.
Pankaj Joshi was appointed as a Director was appointed as a Director on 29 Dec 2016 & has been associated with this company since 8 years 4 months .
Apoorva Kumar Chaudhary was appointed as a Director was appointed as a Director on 29 Dec 2016 & has been associated with this company since 8 years 4 months .
Mensheild Pharmaceutical Private Limited was registered on 29 Dec 2016 with Roc Kanpur & aged 8 years 4 months as per MCA records.
Mensheild Pharmaceutical Private Limited was incorporated on 29 Dec 2016.
The authorized share capital of Mensheild Pharmaceutical Private Limited is ₹ 1.00 M and paid-up capital is ₹ 1.00 M.
Currently 2 directors are associated with Mensheild Pharmaceutical Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Mensheild Pharmaceutical Private Limited is 50A, Swaroop Park Sahibabad India, Ghaziabad, Uttar Pradesh, 201005.
The corporate identification number (CIN) of Mensheild Pharmaceutical Private Limited is U74999UP2016PTC088766 and the company number is 088766 as per Ministry of Corporate Affairs (MCA).
The most recent Balance Sheet for Mensheild Pharmaceutical Private Limited was filed with the ROC on 31 Mar 2018.
Search company & director profiles for free and gain access to critical business data.